What is the official website of Bayer | Ophthalmology ?

The official website of Bayer | Ophthalmology is https://ophthalmology.bayer.com/.

What is Bayer | Ophthalmology's cybersecurity risk score?

Bayer | Ophthalmology has an AI-generated cybersecurity risk score of 759 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Bayer | Ophthalmology experienced?

According to Rankiteo, Bayer | Ophthalmology currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Bayer | Ophthalmology been affected by any supply chain cyber incidents ?

According to Rankiteo, Bayer | Ophthalmology has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Bayer | Ophthalmology have SOC 2 Type 1 certification ?

According to Rankiteo, Bayer | Ophthalmology is not certified under SOC 2 Type 1.

Does Bayer | Ophthalmology have SOC 2 Type 2 certification ?

According to Rankiteo, Bayer | Ophthalmology does not hold a SOC 2 Type 2 certification.

Does Bayer | Ophthalmology comply with GDPR ?

According to Rankiteo, Bayer | Ophthalmology is not listed as GDPR compliant.

Does Bayer | Ophthalmology have PCI DSS certification ?

According to Rankiteo, Bayer | Ophthalmology does not currently maintain PCI DSS compliance.

Does Bayer | Ophthalmology comply with HIPAA ?

According to Rankiteo, Bayer | Ophthalmology is not compliant with HIPAA regulations.

Does Bayer | Ophthalmology have ISO 27001 certification ?

According to Rankiteo,Bayer | Ophthalmology is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Bayer | Ophthalmology operate in ?

Bayer | Ophthalmology operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Bayer | Ophthalmology have ?

Bayer | Ophthalmology employs approximately None employees people worldwide.

Does Bayer | Ophthalmology own any subsidiaries ?

Bayer | Ophthalmology presently has no subsidiaries across any sectors.

How many LinkedIn followers does Bayer | Ophthalmology have ?

Bayer | Ophthalmology's official LinkedIn profile has approximately 21,320 followers.

What is the NAICS classification code for Bayer | Ophthalmology ?

Bayer | Ophthalmology is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Bayer | Ophthalmology have a Crunchbase profile ?

No, Bayer | Ophthalmology does not have a profile on Crunchbase.

Does Bayer | Ophthalmology have a LinkedIn profile ?

Yes, Bayer | Ophthalmology maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/bayerophthalmology.

How many cybersecurity incidents has Bayer | Ophthalmology experienced ?

As of September 15, 2026, Rankiteo reports that Bayer | Ophthalmology has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Bayer | Ophthalmology have ?

Bayer | Ophthalmology has an estimated 5,763 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Boost Score +25 with badge (5 left)

759

/1000

Fair

784

/1000

Fair

Bayer | Ophthalmology Vendor Cyber Rating & Cyber Score

bayer.com

Add Your Compliance Badge

Retinal disease represents a major global health burden, especially as the world population ages and grows. Experts estimate that today at least one billion people live with vision impairment that could have been prevented or has yet to be addressed. Social Media Privacy Statement: https://www.bayer.com/en/glob-li-bayer-en-dps-imprint.aspx

Bayer | Ophthalmology CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Bayer | Ophthalmolo...

Breach

8/2025

BAY393433911032...

Loading…

A.I.

BO Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BO

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Bayer | Ophthalmology in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Bayer | Ophthalmology in 2026.

Incident Types BO vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Bayer | Ophthalmology in 2026.

Incident History - BO (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Bayer | Ophthalmology Subsidiaries

BO

Pharmaceutical Manufacturing

Website: https://ophthalmology.bayer.com/

Company Size: 10,001+ employees

BayerChemical Manufacturing

WOMEN | BayerPharmaceutical Manufacturing

Bayer | PharmaceuticalsArzneimittelherstellung

ClimateTechnology, Information and Internet

Bayer Crop Science | Innovation EcosystemResearch Services

Digital Hub Warsaw I BayerProdukcja wyrobów chemicznych

Loading…

Bayer | Ophthalmology Similar Companies

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Loading…

NEWS

Bayer | Ophthalmology CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

October 04, 2025 04:01 AM

Investment in Autonomous AI, IoT to shape the future of healthcare, cybersecurity- Alaofin

Matthew Alaofin, Senior Advisor at Dell Technologies, USA has disclosed the importance of investment in Autonomous AI and IoT in shaping...

Read Article

October 01, 2025 06:22 PM

AI deepfakes are redefining cybersecurity: Expert warns ‘Verify First, Then Trust’

What began as crude phishing emails riddled with spelling mistakes has now evolved into a high-stakes battle against artificial...

Read Article

September 25, 2025 06:56 PM

How Bayer closed the distance globally between planning and activating

A new global business services model needed buy-in across four continents. EY wavespace™ brought execs together to drive inclusive growth.

Read Article

September 21, 2025 07:00 AM

Bayer India expert: Freshers jobs now more about skills than degrees; AI, ML rarely taught effectively

While hospitality, healthcare sectors boom for freshers, outdated college curriculum fail to impart AI, ML skills; startups fuel jobs for...

Read Article

September 16, 2025 07:00 AM

Cybersecurity Firm Netskope Lifts IPO Target, Seeks $908 Million

Netskope Inc. raised the price of its initial public offering, boosting the potential deal size to $908.2 million from $812.6 million as the...

Read Article

September 10, 2025 07:00 AM

Lynch Carpenter Investigates Claims in Retina Group of Florida Data Breach

PITTSBURGH, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Retina Group of Florida (“RGF”) recently announced a cybersecurity incident, which impacted...

Read Article

August 11, 2025 07:00 AM

Information Commissioner sues Optus over 2022 data breach

Telecommunications giant Optus faces potential civil penalties of up to $20.9 trillion after the Office of the Australian Information...

Read Article

July 29, 2025 07:00 AM

Cybersecurity jobs available right now: July 29, 2025

Here are the worldwide cybersecurity job openings available as of July 29, 2025, including on-site, hybrid, and remote roles.

Read Article

June 16, 2025 07:00 AM

Nagaland Police Issues Cybersecurity Alert Over Fake ‘PM Kisan Yojana’ APK Targeting Mobile Devices

The Nagaland Police has issued a cybersecurity advisory warning citizens about a malicious mobile application falsely branded as “PM Kisan Yojana.”

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-91201

SUMMARY

DocsGPT through 0.20.0 posts OAuth connector session tokens to a wildcard target origin in the callback-status endpoint without validating sender origin. Attackers can obtain session tokens and provider account emails by acting as window.opener during OAuth authorization, then use tokens to disconnect victims' cloud storage connectors.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-91200

SUMMARY

DevSpace through 6.3.21 fails to reject parent-directory segments in tar entry names from the in-pod sync stream. Attackers operating a malicious container can stream tar entries with traversal sequences to write arbitrary files on the developer workstation, enabling code execution.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-91199

SUMMARY

Refly through 1.1.0 contains a server-side request forgery vulnerability in the POST /v1/misc/scrape endpoint that fetches caller-supplied URLs without validating the scheme, host, or resolved address. Authenticated attackers can make the backend issue requests to loopback, private, and link-local addresses including cloud metadata services to read page titles and descriptions of internal resources.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 5)

cvss3

Base Score: 5.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.1

REFERENCES

CVE-2026-91198

SUMMARY

GrowthBook through 5.0.1 returns unredacted fact table definitions including raw warehouse SQL in payloads served by unauthenticated public report and experiment endpoints. Attackers with knowledge of a publicly shared report or experiment identifier can read internal data warehouse query text, schema, table names, filter values and datasource identifiers.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-91197

SUMMARY

Flowable flowable-engine through 8.0.0 contains an XML external entity injection vulnerability in ProcessDiagramLayoutFactory.parseXml() that fails to disable external entity resolution when parsing deployed BPMN resources. Attackers with process deployment privileges can embed DOCTYPE declarations with external entities in BPMN files to read arbitrary local files or trigger requests to internal network endpoints when diagram layout is computed.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Bayer | Ophthalmology Vendor Cyber Rating & Cyber Score

BO A.I CyberSecurity Scoring

Bayer | Ophthalmology CyberSecurity News & History

BO Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for BO

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types BO vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - BO (X = Date, Y = Severity)

Bayer | Ophthalmology Subsidiaries

BO

Bayer | Ophthalmology Similar Companies

Zydus Group

MSD

SUN PHARMA

Novartis

Hikma Pharmaceuticals

Glenmark Pharmaceuticals

Bristol Myers Squibb

Torrent Pharmaceuticals Ltd

Alembic Pharmaceuticals Limited

Bayer | Ophthalmology CyberSecurity News

Investment in Autonomous AI, IoT to shape the future of healthcare, cybersecurity- Alaofin

AI deepfakes are redefining cybersecurity: Expert warns ‘Verify First, Then Trust’

How Bayer closed the distance globally between planning and activating

Bayer India expert: Freshers jobs now more about skills than degrees; AI, ML rarely taught effectively

Cybersecurity Firm Netskope Lifts IPO Target, Seeks $908 Million

Lynch Carpenter Investigates Claims in Retina Group of Florida Data Breach

Information Commissioner sues Optus over 2022 data breach

Cybersecurity jobs available right now: July 29, 2025

Nagaland Police Issues Cybersecurity Alert Over Fake ‘PM Kisan Yojana’ APK Targeting Mobile Devices

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Bayer | Ophthalmology CyberSecurity News & History

BO Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for BO

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types BO vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - BO (X = Date, Y = Severity)

Bayer | Ophthalmology Subsidiaries

BO

Bayer | Ophthalmology Similar Companies

Zydus Group

MSD

SUN PHARMA

Novartis

Hikma Pharmaceuticals

Glenmark Pharmaceuticals

Bristol Myers Squibb

Torrent Pharmaceuticals Ltd

Alembic Pharmaceuticals Limited

Bayer | Ophthalmology CyberSecurity News

Investment in Autonomous AI, IoT to shape the future of healthcare, cybersecurity- Alaofin

AI deepfakes are redefining cybersecurity: Expert warns ‘Verify First, Then Trust’

How Bayer closed the distance globally between planning and activating

Bayer India expert: Freshers jobs now more about skills than degrees; AI, ML rarely taught effectively

Cybersecurity Firm Netskope Lifts IPO Target, Seeks $908 Million

Lynch Carpenter Investigates Claims in Retina Group of Florida Data Breach

Information Commissioner sues Optus over 2022 data breach

Cybersecurity jobs available right now: July 29, 2025

Nagaland Police Issues Cybersecurity Alert Over Fake ‘PM Kisan Yojana’ APK Targeting Mobile Devices

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo